Effect of mydriasis degree on intraoperative complications in patients with complicated cataract associated with pseudoexfoliative syndrome
- Autores: Bekmirova B.B.1,2, Frolov M.A.2,3
-
Afiliações:
- Moscow City Policlinic No. 2
- Peoples’ FriendshipUniversity of Russian (RUDN University)
- Buyanow Moscow City Clinical Hospital
- Edição: Volume 29, Nº 3 (2025): ONCOLOGY
- Páginas: 385-396
- Seção: OPHTHALMOLOGY
- URL: https://journals.rcsi.science/2313-0245/article/view/349493
- DOI: https://doi.org/10.22363/2313-0245-2025-29-3-385-396
- EDN: https://elibrary.ru/RATJAU
- ID: 349493
Citar
Texto integral
Resumo
Relevance. Cataract is one of the causes of blindness and low vision among the pathology of the organ of vision. Medication to cure cataracts is extremely ineffective. According to statistics, over the past year, there are about a million patients diagnosed with cataracts. The main method of surgical treatment of cataracts is phacoemulsification. The main cause of a narrow pupil with lens opacities is pseudoexfoliative syndrome, which affects the development of the disease, both in the intraoperative and postoperative periods. The aim of this study is to evaluate the effect of mydriasis on intraoperative complications in patients with complicated cataract in PES. Materials and Methods. The study involved 176 patients of varying severity of PES and a control group without signs of PES. Patients underwent ophthalmological diagnostics (visometry, biomicroscopy, ophthalmoscopy, CCFM, ruler for measuring pupil diameter, pneumotonometry, IOP according to A.N. Maklakov, 10g weight, OST of the anterior segment). In addition to ophthalmological examinations, all patients underwent anamnesis and laboratory tests before surgery according to generally accepted methods. Preoperative preparation of the patient included both drug therapy and a psychological aspect. Particular importance was attached to premedication. All patients in all study groups were prescribed a sedative (per os) 1 hour before surgery. In all observation groups, in order to achieve the cycloplegia required during the operation, instillations of mydriatics were performed according to the scheme. Results and Discussion. Evaluation of the results revealed that the degree of mydriasis is a statistically significant risk factor for the development of all complications except “conjunctiva”. For the conjunctiva, no statistically significant risk factors were found among the selected parameters. AUC for ROC curves are in the range of 0.7–0.9 for all complications, which indicates a good and satisfactory choice of model parameters. In the “photophobia” regression, the risk of developing complications is 6 higher with mydriasis up to 5 mm in the postoperative period, and 26 times higher to get a complication with mydriasis less than 4 mm. In the regression of “chamber moisture” — the moisture of the anterior and posterior chambers, the risk of developing turbid fluid is 353 times higher with mydriasis less than 4 mm, and 27 times higher with mydriasis up to 5 mm. Conclusion. The characteristic signs of pseudoexfoliation syndrome undoubtedly complicate the surgeon’s work: rigid narrow pupil, ciliary muscle weakness, iridodonesis, phacodonesis. When planning cataract surgery, special attention should be paid to diagnosis, history taking in terms of general somatic features, and the choice of mydriatics. This work showed how much the degree of mydriasis can influence complications in the intraoperative period.
Palavras-chave
Sobre autores
Bermet Bekmirova
Moscow City Policlinic No. 2; Peoples’ FriendshipUniversity of Russian (RUDN University)
Autor responsável pela correspondência
Email: Bermet_bekmirova@mail.ru
ORCID ID: 0000-0001-5829-2948
Moscow, Russian Federation
Michael Frolov
Peoples’ FriendshipUniversity of Russian (RUDN University); Buyanow Moscow City Clinical Hospital
Email: Bermet_bekmirova@mail.ru
ORCID ID: 0000-0002-9833-6236
Código SPIN: 1697-6960
Moscow, Russian Federation
Bibliografia
- Aznabaev BM. Ultrasound cataract surgery-phacoemulsification. Мoscow: August Borg; 2005. 136 p. (In Russian).
- Ritch R. Exfoliation syndrome. Curr. Opin. Ophthalmol.2001;12(2):124–130. doi.org/10.1097/00055735-200104000-00008
- Asano N, Schlötzer-Schrehardt UM, Naumann GOH. A histopathologic study of iris changes in pseudoexfoliation syndrome.Ophthalmology.1995;102(9):1279–1290.doi.org/10.1016/s0161-6420 (95) 30873-1
- Akman A, Yilmaz G, Oto S, Akova YA. Comparison of various pupil dilatation methods for phacoemulsification in eyes with a small pupil secondary to pseudoexfoliation.Ophthalmology.2004;111:1693–1698. doi.org/10.1016/j.ophtha.2004.02.008
- Schlotzer — Schrehardt UM, Naumann GOH. Ocular and systematic pseudoexfoliation synfrome. Am. J. of Ophthalmol. 2006;141(5):921–937.doi.org/10.1016/j.ajo.2006.01.047
- Schlotzer–Schrehardt UM, Koca MR, Naumann GO, Volkholz H. Pseudoexfoliation syndrome ocular manifestation of a systemic disorder? Acta Ophthalmol.1992;110:1752–1756.doi.org/10.1001/archopht.1992.01080240092038
- WuDunn D. Genetics. In: Gross R.L. Clinical glaucoma management: clinical signs in diagnosis and therapy. — Philadelphia: W.B. Saunders Company., 2001. — P. 77.doi.org/10.1016/s0002–9394 (01) 01309-5
- Gross R. Clinical glaucoma management: clinical signs in diagnosis and therapy. American Journal of Ophthalmology.2002;133(20):298. doi.org/10.1016/s0002-9394 (01) 01309-5
- Roberts B. Preoperative and postoperative use of nonsteroidal anti-inflammatory drugs in cataract surgery. The Journal of the American Society of Ophthalmic Registered Nurses.1996;21(1):13–16. doi.org/10.1016/s1060-135x(96)90025-1
- Dube P, Boisjoly HM, Bazin R, Chamberland G, Langhera PA, Dube I. Comparison of prednisolone acetate and indomethacin for maintaining mydriasis during cataract surgery. Can.J.Opthalmol. 1990;25(5):234–8
- Dimitrakos S.A., Topouzidis C., Panidou-Kyriakidou I. Prevention of peroperative miosis: comparison between prostaglandin inhibitors. Sodiumdiclofenac and indomethacin in local application. J. Fr. Ophthalmol.1992;15(1):5–8.
- Singh P, Naik TN, Sarkar S, Singh HI, Bhunia SC, Singh YI, Pal SC. Intravenous drug users — a new high — risk group for HIV infections in India.AIDS.1991;5(1):117–118. doi.org/10.1097/00002030-199101000-00026
- Allaire C, Demailly P, Trinquand C. Ocular hypertensive efficacy and safety of once daily carteolol alginate. Br J Ophthalmol 2001;85:921–924. doi.org/10.1136/bjo.85.8.921
- Psilas K, Eftaxias V, Kastanioudakis J, Kalogeropoulos C. Silicone intubation as an alternative to dacryocystorhinostomy for nasolacrimal drainage obstruction in adults. Eur. J. Ophthalmol.1993;3(2):71–76. doi.org/10.1177/112067219300300204
- Solomon KD, Cheetham JK, DeGryse R, Brint SF, Rosenthal A. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology. 2001;108(2):331–337. doi.org/10.1016/s0161-6420 (00) 00543-1
- Chaudhary KP, Sofat BK. Preoperative topical flurbiprofen-Na in extracapsular lens extraction role in maintaining intraoperative pupillary dilatation. Indian J. Opthalmol.1992;40(4):109–14.
- Guzinska K. Kaźmierczak D, Dymel M., Pabjańczyk-Wlazło E, Boguń M. Anti-bacterial materials based on hyaluronic acid: Selection of research methodology and analysis of their anti-bacterial properties. Materials Science and Engineering. doi: 10.1016/j.msec.2018.08.043
- Corbett MC, Richards AB. Intraocular adrenaline maintains mydriasis during cataract surgery. Br.J. Ophthalmol. 1994;78:95–98. doi.org/10.1136/bjo.78.2.95
- Liou SW, Chen CC. Maintenance of mydriasis with one bolus of epinephrine injection during phacoemulsifications. J Ocul Pharmacol Ther. 2001;17:249–253. doi.org/10.1089/108076801750295281
- Hempel S, Beiner M, Schröter K, Reissig S, Donth E. Multiple glass transition and nanophase separation in poly (n-alkyl methacrylate) homopolymers. Macromolecules. 1999;32:6278–6282. doi.org/10.1021/ma981780n
- Schlichtenbrede FC, Sarra GM, Stephens C, Bainbridge JWB, Thrasher AJ, Luthert PJ, Ali RR. Kinetics of transgene expression in mouse retina following sub — retinal injections of recombinant adeno — associated virus. Vision Res. 42:541–549. doi.org/10.1016/s0042–6989 (01) 00230-9
- Kumar Vinod, Dushin NV, Frolov MA, Makovetskaya IE, Isufai E. Assessment of the effectiveness and safety of phacoemulsification in patients with pseudoexfoliation syndrome. Modern technologies of cataract and refractive surgery. 2008:146–153.(in Russian)
- Fry DW, Nelson JM. Anti — Cancer Drug Preparation. Membrane Technology.1995;57:10. doi.org/10.1016/s0958-2118 (00) 89127-2
- Patent RUS № 2525512/20.08.2014. Bul. № 23. Postupaeva N.V., Sorokin E.L., Egorov V.V., Postupaev A.V. Sposob medikamentoznogo rasshireniya rigidnogo zrachka pered provedeniem fakoemul’sifikaciej. Available from: https://rusneb.ru/catalog/000224_000128_0002525512_20140820_C1_RU/ (in Russian).
Arquivos suplementares

